webinar register page

Webinar banner
Psychedelics for Alcoholism: From Molecule to Medicine - The Clinical Trial Pathway
Psychedelics for Alcoholism Webinar Series
From Molecule to Medicine: The Clinical Trial Pathway
Clearmind’s Management Team Will Explain the Process Required by the FDA to Approve Clearmind’s Patented MEAI Molecule as a Medicine for Treating Alcohol Use Disorder and Binge Drinking

Jan 26, 2022 09:00 AM in Vancouver

Webinar logo
* Required information